Karyopharm Therapeutics | Aktywa





Aktywa Zmiana Data
AbbVie USD 28.54B 722M 2025-09
Abbott USD 24.84B 371M 2025-09
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 29.94B 1B 2025-09
BioCryst Pharmaceuticals USD 355.68M 42.78M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Eli Lilly USD 62.07B 12.22B 2025-09
Enanta Pharmaceuticals USD 204.34M 18.37M 2025-09
GlaxoSmithKline GBP 17.51B 332M 2025-12
Incyte USD 5.02B 746.01M 2025-12
J&J USD 54.61B 113M 2025-09
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
MacroGenics USD 232.09M 27.15M 2025-09
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Novartis USD 28.2B 2.26B 2025-09
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Takeda JPY 3.12T 195.82B 2025-12
Tectonic Therapeutic USD 273.24M 17.61M 2025-09
TG Therapeutics USD 599.76M 64.2M 2025-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Xencor USD 518.44M 5.29M 2025-09


Karyopharm Therapeutics Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.